Inozyme Pharma, Inc. INZY

Business address

Boston, MA

State

Massachusetts

Incorporated in

Delaware

Industry

Manufacturing (SIC 2834)

SEC CIK

1693011

Accession number

0000950170-25-035939

Items reported in this filing

• Item 2.02 Results of Operations and Financial Condition
• Item 2.05 Costs Associated with Exit or Disposal Activities

  The company reported a restructuring: it committed to exit or dispose of part of its business (for example closing some sites, ending a product line or cutting staff) and expects material costs, under Form 8-K Item 2.05. It does not mean the company is closing; healthy, profitable companies file it too, often alongside an earnings release.

• Item 9.01 Financial Statements and Exhibits

Other entries on the wire for this company

1. 01Jul 2025

   Listing notice

   Inozyme Pharma, Inc. INZY

   Boston, MA Manufacturing Form 8-K, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01

   SEC filing for Inozyme Pharma, Inc. (opens in a new tab)

Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing